Welcome to our dedicated page for Retractable Technologies news (Ticker: RVP), a resource for investors and traders seeking the latest updates and insights on Retractable Technologies stock.
Retractable Technologies, Inc. reports developments tied to its safety medical products business, including VanishPoint® syringes, blood collection and IV catheter products, Patient Safe® syringes, and EasyPoint® retractable needles. The company manufactures and markets devices designed to reduce needlestick injuries, product reuse, and catheter-related contamination risks, with distribution through specialty and general line medical distributors.
Recurring news themes for RVP include operating results, domestic and international sales trends, product mix shifts involving EasyPoint® needles, tariff exposure on products imported from China, and changes in manufacturing activity as the company expands domestic production where practical. Updates also cover workforce reductions, product designations, and dividends on Series II and Series III Class B Convertible Preferred Stock.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Retractable Technologies, Inc. (AMEX: RVP) announced dividends for its Series II and Series III Class B Convertible Preferred Stock, totaling $39,050.00 and $19,061.25, respectively. The dividends have accrued at $1.00 per share from January 1, 2023 to March 31, 2023, with payment scheduled for April 20, 2023, to shareholders of record as of April 10, 2023. Retractable manufactures safety medical products aimed at reducing needlestick injuries, including VanishPoint® syringes and Patient Safe® products.
Retractable Technologies, Inc. (AMEX: RVP) reported a 49.7% decrease in revenues for 2022, totaling approximately $94.8 million compared to $188.4 million in 2021, primarily due to the decline in U.S. government orders for COVID-19 vaccinations. Domestic sales fell 68.8%, while international revenues increased 105%. The company incurred a $853,000 loss from operations and net income dropped to $5.1 million versus $56.1 million in 2021. Operating expenses rose 27.9% due to increased stock option expenses, while share buybacks totaled $7.6 million. Reductions in workforce are expected to save $3.8 million annually.
Retractable Technologies, Inc. (NYSE American: RVP) has announced a workforce reduction of about 22% due to decreased domestic production needs. This decision primarily impacts the production, operations, and logistics departments, aiming for an annual savings of approximately $1.7 million, which is about 13% of its payroll expenses. The expected separation costs are around $154,000. Despite the workforce cut, the company is confident it can maintain its domestic production capacity to meet current demands.
Retractable Technologies, Inc. (RVP) has announced a plan to repurchase 3 million shares of its common stock from BML Investment Partners at $1.60 per share, an 8% discount from the last closing price of $1.74 on December 22, 2022. The company views this repurchase as advantageous due to the stock’s low price, enhancing shareholder value. This strategic move could positively impact earnings per share (EPS) by reducing the total shares outstanding, thereby potentially increasing the stock price in the future.